Obesity is escalating, projected to affect 17.5% of adults globally and afflict 400 million children by 2035. Managing this intricate and chronic condition demands personalized, multidisciplinary approaches. While dietary changes, lifestyle modifications, and medications yield short-term results, long-term outcomes are often poor, with bariatric surgery standing out as the most effective option. However, only a small fraction undergoes surgery due to various barriers. Intragastric balloon (IGB) emerges as a minimally invasive alternative, approved by major regulatory bodies. This review adresses the pivotal role of IGB in obesity management, delving into its history and technological evolution.
Keyphrases
- weight loss
- minimally invasive
- bariatric surgery
- metabolic syndrome
- insulin resistance
- type diabetes
- obese patients
- high fat diet induced
- weight gain
- young adults
- robot assisted
- transcription factor
- coronary artery bypass
- climate change
- physical activity
- adipose tissue
- coronary artery disease
- skeletal muscle
- body mass index
- drug administration
- acute coronary syndrome
- drug induced